An observational study in Persistent Polyclonal B-Cell Lymphocytosis, sponsored by Central Hospital, Nancy, France. Completed at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-28.
Sponsored by Central Hospital, Nancy, France · Observational
The main purpose of this study is the description of all French cases of PPBL and the establishment of minimal criteria for the pathology diagnosis and its follow-up.
The secondary objective is the immunologic and genetic characterization of lymphoid cells causing the disease.
PPBL patients in France
Exclusion Criteria:
Biological: Blood test
30 ml
Relevant medical history
Time frame: Baseline
Complete blood count
Time frame: Baseline
Administration of first-line treatment or not
Time frame: Baseline
Lymphocyte phenotype
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lymphocytosis
Central Hospital, Nancy, France